» Articles » PMID: 38753535

Preclinical Study of Pulsed Field Ablation of Difficult Ventricular Targets: Intracavitary Mobile Structures, Interventricular Septum, and Left Ventricular Free Wall

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Endocardial catheter-based pulsed field ablation (PFA) of the ventricular myocardium is promising. However, little is known about PFA's ability to target intracavitary structures, epicardium, and ways to achieve transmural lesions across thick ventricular tissue.

Methods: A lattice-tip catheter was used to deliver biphasic monopolar PFA to swine ventricles under general anesthesia, with electroanatomical mapping, fluoroscopy and intracardiac echocardiography guidance. We conducted experiments to assess the feasibility and safety of repetitive monopolar PFA applications to ablate (1) intracavitary papillary muscles and moderator bands, (2) epicardial targets, and (3) bipolar PFA for midmyocardial targets in the interventricular septum and left ventricular free wall.

Results: (1) Papillary muscles (n=13) were successfully ablated and then evaluated at 2, 7, and 21 days. Nine lesions with stable contact measured 18.3±2.4 mm long, 15.3±1.5 mm wide, and 5.8±1.0 mm deep at 2 days. Chronic lesions demonstrated preserved chordae without mitral regurgitation. Two targeted moderator bands were transmurally ablated without structural disruption. (2) Transatrial saline/carbon dioxide assisted epicardial access was obtained successfully and epicardial monopolar lesions had a mean length, width, and depth of 30.4±4.2, 23.5±4.1, and 9.1±1.9 mm, respectively. (3) Bipolar PFA lesions were delivered across the septum (n=11) and the left ventricular free wall (n=7). Twelve completed bipolar lesions had a mean length, width, and depth of 29.6±5.5, 21.0±7.3, and 14.3±4.7 mm, respectively. Chronically, these lesions demonstrated uniform fibrotic changes without tissue disruption. Bipolar lesions were significantly deeper than the monopolar epicardial lesions.

Conclusions: This in vivo evaluation demonstrates that PFA can successfully ablate intracavitary structures and create deep epicardial lesions and transmural left ventricular lesions.

Citing Articles

Contemporary Trends in Pulsed Field Ablation for Cardiac Arrhythmias.

Yavin H, Prasad M, Gordon J, Aksu T, Huang H J Cardiovasc Dev Dis. 2025; 12(1).

PMID: 39852288 PMC: 11766314. DOI: 10.3390/jcdd12010010.


Catheter ablation using pulsed-field energy: Do we finally have the magic wand to defeat atrial fibrillation?.

Cristiano E, Ali H, Celentano E, Cappato R World J Cardiol. 2024; 16(12):677-682.

PMID: 39734816 PMC: 11669968. DOI: 10.4330/wjc.v16.i12.677.


Catheter Ablation for Ventricular Tachycardias: Current Status and Future Perspectives.

Kataoka N, Imamura T J Clin Med. 2024; 13(22).

PMID: 39597949 PMC: 11594393. DOI: 10.3390/jcm13226805.


Mapping and ablation of ventricular tachycardia using dual-energy lattice-tip focal catheter: early feasibility and safety study.

Peichl P, Wichterle D, Schlosser F, Stojadinovic P, Nejedlo V, Borisincova E Europace. 2024; 26(11).

PMID: 39478679 PMC: 11577951. DOI: 10.1093/europace/euae275.


Pulsed Field Ablation: A Comprehensive Update.

Ezzeddine F, Asirvatham S, Nguyen D J Clin Med. 2024; 13(17).

PMID: 39274404 PMC: 11396515. DOI: 10.3390/jcm13175191.


References
1.
Turagam M, Neuzil P, Schmidt B, Reichlin T, Neven K, Metzner A . Safety and Effectiveness of Pulsed Field Ablation to Treat Atrial Fibrillation: One-Year Outcomes From the MANIFEST-PF Registry. Circulation. 2023; 148(1):35-46. DOI: 10.1161/CIRCULATIONAHA.123.064959. View

2.
Yavin H, Higuchi K, Sroubek J, Younis A, Zilberman I, Anter E . Pulsed-Field Ablation in Ventricular Myocardium Using a Focal Catheter: The Impact of Application Repetition on Lesion Dimensions. Circ Arrhythm Electrophysiol. 2021; 14(9):e010375. DOI: 10.1161/CIRCEP.121.010375. View

3.
Sandhu U, Alkukhun L, Kheiri B, Hodovan J, Chiang K, Splanger T . In vivo pulsed-field ablation in healthy vs. chronically infarcted ventricular myocardium: biophysical and histologic characterization. Europace. 2023; 25(4):1503-1509. PMC: 10105837. DOI: 10.1093/europace/euac252. View

4.
Nguyen D, Tzou W, Sandhu A, Gianni C, Anter E, Tung R . Prospective Multicenter Experience With Cooled Radiofrequency Ablation Using High Impedance Irrigant to Target Deep Myocardial Substrate Refractory to Standard Ablation. JACC Clin Electrophysiol. 2018; 4(9):1176-1185. DOI: 10.1016/j.jacep.2018.06.021. View

5.
Yokokawa M, Good E, Desjardins B, Crawford T, Jongnarangsin K, Chugh A . Predictors of successful catheter ablation of ventricular arrhythmias arising from the papillary muscles. Heart Rhythm. 2010; 7(11):1654-9. PMC: 2970625. DOI: 10.1016/j.hrthm.2010.07.013. View